Peptide Calculator

Semaglutide Reconstitution Calculator

Convert Semaglutide printed concentration (mg/mL) or reconstituted vial mass into U-100 syringe draw units.

Semaglutide Pre-filled Reconstitution Tool

Pre-loaded with common Semaglutide vial size and reconstitution ratios.

U-100 Syringe Standard
Total compound mass
mg
Added diluent
mL
mcg
Standard U-100
Calculation OutputU-100 Calibrated
Draw Exactly To:
10.0Units
Line 10 on your syringe (0.10 mL volume)
Concentration
2.50 mg/mL
Doses per Vial
20 Doses
Visual Syringe Indicator1.0 mL Syringe

Stored locally on your device (No account needed)

Last updated:
Sources checked: 2026-11-10

📌At a Glance: Semaglutide Reconstitution Arithmetic

  • Known-Concentration Dispensed Products: Pharmacy-dispensed semaglutide solutions typically arrive pre-mixed with a printed concentration (e.g., 2.5 mg/mL or 5.0 mg/mL). If using a pre-mixed liquid solution, no reconstitution is performed; draw volume in mL equals target milligrams divided by concentration.
  • Commercial Formulations: FDA-approved commercial products (Wegovy and Ozempic pre-filled multi-dose pens) come with their own manufacturer delivery mechanisms and are not mixed or drawn into external syringes by the user; follow the official package label.
  • Lyophilized Research Powders: When preparing unformulated research powder, concentration depends strictly on diluent volume added. Refer to our master guide for powder reconstitution arithmetic.
  • Syringe Standard: All volume calculations assume a standard U-100 insulin syringe where 100 graduation units equal 1.0 mL (0.01 mL per unit mark).
⚖️Regulatory & Compound Status
Verified: 2026-11-10

FDA-approved brand formulations (Wegovy and Ozempic pre-filled subcutaneous pens, and Rybelsus oral tablets) come manufactured ready to administer and are not reconstituted by the user; follow official package labeling. Compounded semaglutide products are not FDA-approved, meaning the agency does not evaluate their safety, effectiveness, or manufacturing quality before marketing. The FDA has warned of severe adverse events and hospitalizations caused by dosing calculation errors, emphasized strict cold-chain refrigeration requirements during shipment, and advises that multi-dose sterile vials be used within 28 days of first use due to contamination risks. The FDA's position on unapproved retatrutide is summarized on our Retatrutide Status Page.

ℹ️What This Tool Cannot Tell You
  • What specific dosage amount your body or research subject requires.
  • How to manage clinical escalation protocols or alter milligram quantities.
  • How to diagnose or treat adverse symptoms resulting from medication errors.
  • Whether an unapproved or compounded product is chemically pure or sterile.

This tool converts volumetric liquid measurements and syringe tick marks only. It does not provide medical guidance, dosing schedules, or clinical administration protocols. Review our Medical & Research Disclaimer.

What Is Semaglutide Arithmetic?

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist sharing 94% structural homology with human endogenous GLP-1. Engineered with an alpha-aminoisobutyric acid (Aib) substitution at position 8 to resist dipeptidyl peptidase-4 (DPP-4) enzymatic breakdown and an acylated C18 fatty diacid chain attached via a hydrophilic linker at lysine 26, Semaglutide binds reversibly to plasma albumin. This structural modification extends its circulating elimination half-life to approximately 165 hours (roughly 7 days) as documented in FDA prescribing information.

In clinical and laboratory settings, calculations center around two distinct scenarios: pre-dissolved pharmacy-dispensed solutions with a declared concentration (mg/mL), and dry lyophilized powder cakes requiring reconstitution with bacteriostatic water. Converting milligrams to volume and syringe tick marks using our peptide calculator ensures exact mathematical alignment across standard U-100 syringe graduations.

Semaglutide Known-Concentration Conversion Chart

This reference table translates common pharmacy-dispensed liquid concentrations (mg/mL) into draw volumes and U-100 syringe units. These figures represent volumetric arithmetic across standard U-100 insulin syringes; they are illustrative mathematical conversions, not clinical dose recommendations.

Vial SizeBac Water AddedConcentrationExample AmountDraw Units (U-100)
Dispensed Vial (2.5 mg/mL)Ready Solution2.50 mg/mL0.25 mg (250 mcg)10.0 Units
Dispensed Vial (2.5 mg/mL)Ready Solution2.50 mg/mL0.50 mg (500 mcg)20.0 Units
Dispensed Vial (2.5 mg/mL)Ready Solution2.50 mg/mL1.00 mg (1,000 mcg)40.0 Units
Dispensed Vial (5.0 mg/mL)Ready Solution5.00 mg/mL0.50 mg (500 mcg)10.0 Units
Dispensed Vial (5.0 mg/mL)Ready Solution5.00 mg/mL1.00 mg (1,000 mcg)20.0 Units
Dispensed Vial (5.0 mg/mL)Ready Solution5.00 mg/mL2.00 mg (2,000 mcg)40.0 Units

Worked Math Example: Known-Concentration Dispensed Solution

Example Parameters:
  • Pharmacy-dispensed solution concentration: 2.5 mg/mL
  • Target amount: 0.50 mg (500 mcg)
  • Syringe standard: U-100 insulin syringe (100 units = 1.0 mL)
Step-by-Step Calculation:
  1. Step 1: Calculate draw volume in milliliters: Target Mass (0.50 mg) ÷ Printed Concentration (2.5 mg/mL) = 0.20 mL.
  2. Step 2: Convert milliliters to U-100 syringe units: 0.20 mL × 100 units/mL = 20.0 units.
  3. Step 3: Verification back-check: 20 units × 0.01 mL/unit = 0.20 mL. 0.20 mL × 2.5 mg/mL = 0.50 mg active compound.
  4. Step 4: Lyophilized powder note: If preparing unformulated research powder from scratch, first establish concentration using: Concentration (mg/mL) = Vial Mass (mg) ÷ Bacteriostatic Water Volume (mL). Review our master guide for step-by-step powder mixing formulas.
Result:

Draw exactly to the 20.0 unit mark on a standard U-100 syringe for a 0.50 mg aliquot from a 2.5 mg/mL solution.

Note: Illustrative arithmetic only. Always verify your specific prescription label or laboratory protocol before drawing.

Why Semaglutide Vial Math Causes Documented Dosing Errors

In public safety communications, the U.S. Food and Drug Administration (FDA) highlighted widespread adverse events resulting from mathematical miscalculations with compounded semaglutide. These errors occur because three entirely different measurement systems intersect: pen dial markers calibrated in milligrams, liquid vial labels formulated in milligrams per milliliter (mg/mL), and hypodermic insulin syringes calibrated in arbitrary volumetric 'units'.

A critical misunderstanding is assuming that a syringe 'unit' represents a fixed quantity of peptide. On a standard U-100 syringe, one unit is strictly a volumetric measure equal to 0.01 mL (1/100th of a milliliter). The actual mass of semaglutide delivered by each unit is governed entirely by the concentration of the liquid. In a 2.5 mg/mL solution, each unit delivers 25 mcg (0.025 mg). In a 5.0 mg/mL solution, each unit delivers 50 mcg (0.050 mg). Operating with the wrong concentration assumption results in immediate double- or half-dosing errors.

Ready-Mixed Pharmacy Concentrations: Many clinical preparations and pharmacy-dispensed vials arrive pre-compounded as a ready liquid with a printed concentration on the vial label (for example, 2.5 mg/mL or 5.0 mg/mL). In these cases, no reconstitution is required. You skip diluent addition entirely. To calculate syringe units from a known liquid concentration, divide your target milligram amount by the label concentration, then multiply by 100: (Target mg ÷ Label mg/mL) × 100 = U-100 Syringe Units. For powder reconstitution from freeze-dried cakes, review our dedicated peptide reconstitution master guide.

Syringe Draw Units for Known-Concentration Solutions

When a solution has a known concentration of either 2.5 mg/mL or 5.0 mg/mL, use this lookup table to find the corresponding syringe line markings for evenly spaced round test amounts. All calculations assume a standard U-100 (100 units = 1.0 mL) syringe.

Target AmountDraw Units at 2.5 mg/mL (0.025 mg/unit)Draw Units at 5.0 mg/mL (0.050 mg/unit)
0.25 mg (250 mcg)10.0 Units (0.10 mL)5.0 Units (0.05 mL)
0.50 mg (500 mcg)20.0 Units (0.20 mL)10.0 Units (0.10 mL)
1.00 mg (1,000 mcg)40.0 Units (0.40 mL)20.0 Units (0.20 mL)
2.00 mg (2,000 mcg)80.0 Units (0.80 mL)40.0 Units (0.40 mL)

Chemical Handling & Physical Stability of Liquid Semaglutide

Semaglutide is a 31-amino-acid polypeptide stabilized by a C18 diacid chain. While robust in aqueous solution, the peptide chain remains vulnerable to thermal degradation and physical agitation. Vials must be stored upright under refrigeration between 2°C and 8°C (36°F to 46°F) and shielded from light. Liquid solutions must never be frozen. Avoid vigorous shaking, which induces frothing and accelerates aggregation. The FDA recommends discarding multi-dose sterile vials within 28 days of first puncture due to microbial contamination hazards. For comprehensive preparation principles, see our tutorial on how to calculate peptide dosage.

Common Calculation & Measurement Mistakes

⚠️Equating Syringe Units with Milligrams

Believing that 25 units equals 25 mg is a 100-fold overdose hazard. On a U-100 syringe, 25 units is 0.25 mL of fluid. The milligram amount depends completely on solution concentration.

⚠️Reusing Remembered Unit Marks After Changing Diluent Volume

If you previously drew 10 units from a vial mixed with 1 mL of water, and then mix your next vial with 2 mL of water, drawing 10 units cuts the delivered compound by exactly 50%. Always recalculate when water volume changes.

⚠️Translating Pen Dial Numbers to Syringe Vials

Commercial pre-filled pens (such as Wegovy or Ozempic) use calibrated mechanical dials that dispense fixed micro-volumes from proprietary cartridges. Never assume numbers printed on a pen dial correspond to graduation lines on an insulin syringe.

⚠️Using U-40 Syringes with U-100 Mathematical Conversions

U-40 veterinary syringes contain 40 units per milliliter (1 unit = 0.025 mL), whereas U-100 syringes contain 100 units per milliliter (1 unit = 0.01 mL). Drawing to a '20 unit' mark on a U-40 syringe delivers 0.50 mL of fluid—2.5 times more than the 0.20 mL delivered by 20 units on a U-100 syringe.

⚠️Attempting to Reconstitute Pre-Mixed Liquid Vials

Some clinical vials are shipped pre-dissolved in sterile liquid by a compounding pharmacy. Adding bacteriostatic water to an already-dissolved solution dilutes the labeled concentration and invalidates all future calculations.

How Semaglutide Compares with Tirzepatide

Within metabolic peptide research, Semaglutide is a selective mono-GLP-1 receptor agonist. By contrast, Tirzepatide is a dual GIP and GLP-1 receptor agonist, requiring distinct milligram ranges and often handled in larger vial sizes where liquid measurement resolution becomes critical. When converting numbers across these calculators, remember that each molecule possesses a distinct molecular mass and volumetric ratio; never transfer volumetric draw numbers between different peptide compounds.

Standard Semaglutide Reconstitution Guidelines

When handling unformulated lyophilized powder, reconstitution requires aseptic technique and gentle diluent introduction down the inner vial wall.

Syringe Reading Diagram

U-100 Syringe Graduation & Measurement Line (Semaglutide)

010 U20304050 U (0.5 mL)60708090100 U (1.0 mL)Align Leading Black Ring to 10 Units

Standard Reconstitution Protocol

Lyophilized semaglutide follows standard laboratory reconstitution protocols. Always introduce diluent smoothly against the inner vial wall and allow natural dissolution without shaking.

View the complete standard peptide reconstitution guide→

❄️ Storage & Shelf-Life Notice (Semaglutide)

Store reconstituted multi-dose vials refrigerated at 2°C–8°C (36°F–46°F), protect from heat and direct sunlight, and never freeze. Under FDA multi-dose sterile vial guidance, discard opened multi-dose vials within 28 days of first puncture.

⚠️ Common Preparation Mistakes to Avoid

Shaking the vial causing foaming and chain breakage, confusing units with milligrams, and freezing liquid peptide solutions.

Semaglutide Dosing FAQ

Is one syringe unit the same as one milligram?↓
No. On a standard U-100 syringe, one unit equals 0.01 mL of liquid volume. The mass of semaglutide contained within that 0.01 mL depends entirely on the solution's concentration. In a 2.5 mg/mL solution, one unit contains 25 mcg (0.025 mg). Confusing units with milligrams can lead to severe measurement errors.
My vial is already liquid. Do I add bacteriostatic water?↓
No. If your vial arrived as a clear pre-dissolved liquid from a pharmacy, it has already been compounded to a specific concentration (such as 2.5 mg/mL or 5.0 mg/mL). Adding water will dilute the formulation and invalidate the labeled strength. Simply use the concentration printed on the vial to calculate syringe units.
Why do two calculators give different unit numbers for the same vial?↓
Two calculators will produce different unit numbers if they assume different volumes of bacteriostatic water, different concentrations, or different syringe calibrations (such as U-100 versus U-40). For example, drawing 0.5 mg from a 2.5 mg/mL solution requires 20 units, while drawing from a 5.0 mg/mL solution requires only 10 units. Always verify the concentration.
Does this calculation replace the dial on a commercial pen?↓
No. Commercial pre-filled pens (such as Wegovy or Ozempic) contain proprietary cartridges calibrated to mechanical click-dials. Syringe calculations apply strictly to multi-dose vials drawn using external hypodermic insulin syringes and should never be applied to pen dials.
How do I check my calculation backwards to confirm accuracy?↓
To perform a mathematical back-check: multiply your syringe units by 0.01 mL to get draw volume (e.g., 20.0 units × 0.01 = 0.20 mL). Then multiply that volume by your liquid concentration (0.20 mL × 2.5 mg/mL = 0.50 mg). If the resulting mass matches your target amount, your calculation is mathematically sound.

Related Peptide Calculators & Stacks

Related Reconstitution & Dosing Guides

View All FAQs→

Scientific & Regulatory References

View Full Sources Registry→

The mathematical formulas on this page are deterministic volumetric conversions. Non-mathematical parameters, regulatory status notes, and chemical safety guidelines are referenced directly to the primary sources cataloged below:

  1. [1]
    Wegovy (semaglutide injection) Highlights of Prescribing Information
    U.S. National Library of Medicine (DailyMed / FDA)•Type: fda label•Verified: 2026-11-08

    FDA prescribing label outlining official pen formulation concentrations and storage parameters.

  2. [2]
    Ozempic (semaglutide injection) Highlights of Prescribing Information
    U.S. National Library of Medicine (DailyMed / FDA)•Type: fda label•Verified: 2026-11-08

    FDA prescribing information for pre-filled multi-dose semaglutide delivery pen.

  3. [3]
    FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
    U.S. Food and Drug Administration (FDA CDER)•Type: fda communication•Verified: 2026-11-08

    FDA safety alert detailing risks of unapproved compounded GLP-1 drugs, dosing errors, lack of pre-market review, improper cold-chain shipping temperatures, and recommendation to discard multi-dose sterile vials 28 days after first puncture.

  4. [4]
    Embecta Ultra-Fine™ U-100 Insulin Syringe Product Specifications
    embecta (formerly BD Diabetes Care)•Type: manufacturer spec•Verified: 2026-11-08

    Manufacturer specifications for sterile single-use U-100 insulin syringes (0.3 mL, 0.5 mL, and 1.0 mL capacities with 1-unit and 1/2-unit scales).

  5. [5]
    USP General Chapter <797>: Pharmaceutical Compounding — Sterile Preparations
    United States Pharmacopeial Convention (USP)•Type: standard•Verified: 2026-10-20

    Standards for beyond-use dates (BUD), refrigeration controls (2°C–8°C), and multi-dose sterility.